Helix BioMedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Sep '12 Sep 30, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007
Revenue	2.07	1.89	0.85	0.39	0.56	0.46
Revenue Growth (YoY)	14.56%	122.07%	117.67%	-30.49%	21.32%	553.99%
Cost of Revenue	0.64	0.73	0.26	0.2	0.26	0.14
Gross Profit	1.42	1.16	0.59	0.19	0.31	0.33
Selling, General & Admin	3.37	2.95	2.68	2.56	2.89	2.89
Research & Development	0.38	0.5	0.75	0.72	0.83	0.78
Operating Expenses	3.85	3.56	3.55	3.41	3.85	3.84
Operating Income	-2.42	-2.4	-2.96	-3.22	-3.54	-3.52
Interest Expense	-0.11	-	-0.89	-0.57	-1.04	-
Interest & Investment Income	0	0	0	0.01	0.06	0.08
Earnings From Equity Investments	-0.04	-0.09	-0.07	-	-	-
EBT Excluding Unusual Items	-2.58	-2.49	-3.91	-3.78	-4.53	-3.43
Gain (Loss) on Sale of Investments	-0.01	-0.01	0	-	-	-
Gain (Loss) on Sale of Assets	0.01	0.01	-	-	-	-
Other Unusual Items	-	-	-3.81	-	0.01	-
Pretax Income	-2.58	-2.49	-7.71	-3.78	-4.52	-3.43
Net Income	-2.58	-2.49	-7.71	-3.78	-4.52	-3.43
Net Income to Common	-2.58	-2.49	-7.71	-3.78	-4.52	-3.43
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change (YoY)	10.06%	83.31%	5.73%	-	2.04%	12.52%
EPS (Basic)	-15.59	-15.02	-85.28	-44.15	-52.81	-40.98
EPS (Diluted)	-15.59	-15.02	-85.28	-44.15	-52.81	-40.98
Free Cash Flow	-1.83	-2.3	-2.8	-3.09	-3.15	-3.24
Free Cash Flow Per Share	-11.04	-13.87	-30.99	-36.12	-36.89	-38.65
Gross Margin	68.96%	61.23%	69.41%	49.77%	54.63%	70.15%
Operating Margin	-117.30%	-127.12%	-347.10%	-822.43%	-629.65%	-758.41%
Profit Margin	-125.06%	-131.58%	-905.36%	-964.82%	-802.22%	-740.18%
Free Cash Flow Margin	-88.57%	-121.54%	-329.02%	-789.38%	-560.37%	-698.14%
EBITDA	-2.33	-2.3	-2.84	-3.09	-3.41	-3.34
EBITDA Margin	-112.72%	-121.35%	-	-	-	-
D&A For EBITDA	0.09	0.11	0.11	0.13	0.13	0.17
EBIT	-2.42	-2.4	-2.96	-3.22	-3.54	-3.52
EBIT Margin	-117.30%	-127.12%	-	-	-	-
Revenue as Reported	2.07	1.89	0.85	0.39	0.56	0.46
Advertising Expenses	-	0.15	0.04	0.03	0.02	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.